advertisement
Pfeiffer N 40
Showing records 1 to 25 | Display all abstracts from Pfeiffer N72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Lorenz K
Trials 2017; 18: 128
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Anders F
PLoS ONE 2017; 12: e0175451
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Höhn R
British Journal of Ophthalmology 2017; 101: 1633-1637
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Funke S
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Marx-Gross S
Deutsches Ärzteblatt international 2017; 114: 204-210
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Perumal N
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Laubert-Reh D
Deutsches Ärzteblatt international 2017; 114: 204-210
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Scheller Y
Trials 2017; 18: 128
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Teister J
PLoS ONE 2017; 12: e0175451
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Mirshahi A
British Journal of Ophthalmology 2017; 101: 1633-1637
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Bell K
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Schneider A
Deutsches Ärzteblatt international 2017; 114: 204-210
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Liu A
PLoS ONE 2017; 12: e0175451
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Bell K
Trials 2017; 18: 128
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Nickels S
British Journal of Ophthalmology 2017; 101: 1633-1637
72845 The Prevalence of Glaucoma in Young People
Höhn R
Deutsches Ärzteblatt international 2017; 114: 204-210
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Grus F
Trials 2017; 18: 128
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Schulz A
British Journal of Ophthalmology 2017; 101: 1633-1637
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Funke S
PLoS ONE 2017; 12: e0175451
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Pfeiffer N
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Mirshahi A
Deutsches Ärzteblatt international 2017; 114: 204-210
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Wild PS
British Journal of Ophthalmology 2017; 101: 1633-1637
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Grus FH
Expert review of proteomics 2017; 14: 311-334
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Ponto KA
Trials 2017; 18: 128
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Grus FH; Thanos S
PLoS ONE 2017; 12: e0175451
